Prenatal sonographic assessment of early,rapidly growing fetal cervical teratoma

Although malignant transformation of fetal cervical teratoma is extremely rare, perinatal morbidity is high and usually related to the size of the tumour, which may compromise fetal swallowing and subsequently lead to upper airway obstruction. We present a case in which mid-trimester serial sonography demonstrated markedly rapid early growth of a lesion of this type between 17 and 19 weeks' gestation indicating the aggressive nature of this tumour, assisting parental decision to terminate the pregnancy. Histopathology confirmed grade 3 immaturity of the lesion.     

Effect of long-term fertilization on soil nitrate distribution

ＩｎｔｒｏｄｕｃｔｉｏｎＦｅｒｔｉｌｉｚａｔｉｏｎｉｓｅｓｓｅｎｔｉａｌｆｏｒａｇｒｉｃｕｌｔｕｒａｌｐｒｏｄｕｃｔｉｏｎ ,ｂｕｔｕｎｒｅａｓｏｎａｂｌｙａｐｐｌｙｉｎｇｆｅｒｔｉｌｉｚｅｒｓｃｏｕｌｄｒｅｓｕｌｔｉｎｓｅｒｉｅｓｏｆｐｒｏｂｌｅｍｓｓｕｃｈａｓｃｒｏｐｑｕａｌｉｔｙｄｅｃｌｉｎｅ,ｆｅｒｔｉｌｉｚｅｒｕｓｅｅｆｆｉｃｉｅｎｃｙｄｅｃｒｅａｓｅ,ｒｅｓｉｄｕａｌｆｅｒｔｉｌｉｚｅｒｓｐｏｌｌｕｔｉｏｎ ｇｒｏｕｎｄｗａｔｅｒａｎｄｒｉｖｅｒｓａｎｄｎｉｔｒｏｇｅｎｃｏｎｔｅｎｔｅｄ …     

Fluoride distibution and the effect of some ions along Alexandria coastal Mediterranean seawater of Egypt

The coastal seawater of Mediterranean of Alexandria receives large amount of discharged waters containing industrial wastes, sewage, and agricultural and domestic drainage. Fluoride and some parameters were(chemical and physical) determined. The data gave indication that the content and the amount of the discharged water largely affect the chemical composition of the coastal water. Stepwise regression analysis was highly significant and the model was very fruitful, where the observed and calculated values were mostly concordant. This may indicated that there was a relation between fluoride content in coastal seawater and its content in the discharged water.     

Prenatal diagnosis of Freeman–Sheldon syndrome (whistling face)

The diagnosis of Freeman–Sheldon syndrome was made by ultrasonographic evaluation of a 20-week fetus with a positive family history. The ultrasonographic features were abnormalities of the extremities and mouth.     

Pitfalls in the prenatal diagnosis of peroxisomal β-oxidation defects by chorionic villus sampling

Variability in the level of expression of very long chain fatty acids (VLCFAs) is documented in cultured chorionic villus (CV) cells derived from two fetuses, one at risk for an unusual peroxisomal fatty acid β-oxidation defect, and the other at risk for the X-linked form of adrenoleucodystrophy (ALD). Cells from early subcultures of chorionic cells from both cases gave normal values for VLCFA ratios. The results for the fetus at risk for the β-oxidation defect were interpreted to indicate that the fetus was not affected; however, at birth, the infant was clinically and biochemically affected. In the case of the fetus at risk for X-linked ALD, although VLCFAs were normal in subculture 1, the levels of these fatty acids increased dramatically in subculture 3, suggesting an abnormal fetus. Termination of the pregnancy and subsequent biochemical and morphological follow-up confirmed that the fetus was indeed affected by ALD.     

Second-trimester cancer antigen 125 and Down's syndrome

This study explores if assay of cancer antigen 125 (CA 125) in maternal serum might aid the detection of Down's syndrome in the second trimester of pregnancy. CA 125 levels were determined retrospectively in stored maternal serum samples from ten Down's syndrome pregnancies and 78 controls matched for gestational and maternal age. In addition, second-trimester amniotic fluid samples from nine Down's syndrome and 109 unaffected pregnancies were analysed for CA 125. Maternal serum CA 125 values for Down's syndrome pregnancies were lower, with the median being 0.72 multiples of the unaffected population median. The medians for affected and unaffected pregnancies did not differ significantly and there was a considerable overlap in the range of values of cases and controls. The distribution of amniotic fluid CA 125 levels for Down's syndrome pregnancies resembled that for controls. From our present results, we could not find an association between Down's syndrome and second-trimester maternal serum or amniotic fluid CA 125 levels.